Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Cumberland, RI
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Cumberland, RI
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Anderson, SC
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Greer, SC
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
North Charleston, SC
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
North Charleston, SC
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Rapid City, SD
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Chattanooga, TN
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Memphis, TN
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Milan, TN
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Milan, TN
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Austin, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Houston, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Hurst, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Hurst, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
N. Richland Hills, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
N. Richland Hills, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
San Antonio, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Sugarland, TX
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Sugarland, TX
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
St. George, UT
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
St. George, UT
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
West Jordan, UT
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Christiansburg, VA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Christiansburg, VA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Richmond, VA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Richmond, VA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Bellevue, WA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Spokane, WA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Gulf Shores, AL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Mesa, AZ
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
North Little Rock, AR
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Fresno, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Long Beach, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Norco, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Norco, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Oceanside, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Sacramento, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Stamford, CT
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Bradenton, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Brandon, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Brookville, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Brookville, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Clermont, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Clermont, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Kissimee, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Kissimee, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Maitland, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials